35026048|t|Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia.
35026048|a|Hexanucleotide repeat expansions in C9orf72 are the most common cause of familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The mechanisms by which the expansions cause disease are not properly understood but a favoured route involves its translation into dipeptide repeat (DPR) polypeptides, some of which are neurotoxic. However, the precise targets for mutant C9orf72 and DPR toxicity are not fully clear, and damage to several neuronal functions has been described. Many of these functions are regulated by signalling between the endoplasmic reticulum (ER) and mitochondria. ER-mitochondria signalling requires close physical contacts between the two organelles that are mediated by the VAPB-PTPIP51 'tethering' proteins. Here, we show that ER-mitochondria signalling and the VAPB-PTPIP51 tethers are disrupted in neurons derived from induced pluripotent stem (iPS) cells from patients carrying ALS/FTD pathogenic C9orf72 expansions and in affected neurons in mutant C9orf72 transgenic mice. In these mice, disruption of the VAPB-PTPIP51 tethers occurs prior to disease onset suggesting that it contributes to the pathogenic process. We also show that neurotoxic DPRs disrupt the VAPB-PTPIP51 interaction and ER-mitochondria contacts and that this may involve activation of glycogen synthase kinases-3beta (GSK3beta), a known negative regulator of VAPB-PTPIP51 binding. Finally, we show that these DPRs disrupt delivery of Ca2+ from ER stores to mitochondria, which is a primary function of the VAPB-PTPIP51 tethers. This delivery regulates a number of key neuronal functions that are damaged in ALS/FTD including bioenergetics, autophagy and synaptic function. Our findings reveal a new molecular target for mutant C9orf72-mediated toxicity.
35026048	58	65	C9orf72	Gene	203228
35026048	77	106	amyotrophic lateral sclerosis	Disease	MESH:D000690
35026048	111	134	frontotemporal dementia	Disease	MESH:D057180
35026048	172	179	C9orf72	Gene	203228
35026048	209	247	familial amyotrophic lateral sclerosis	Disease	MESH:C531617
35026048	249	252	ALS	Disease	MESH:D000690
35026048	258	281	frontotemporal dementia	Disease	MESH:D057180
35026048	283	286	FTD	Disease	MESH:D057180
35026048	476	486	neurotoxic	Disease	MESH:D020258
35026048	528	535	C9orf72	Gene	203228
35026048	544	552	toxicity	Disease	MESH:D064420
35026048	856	860	VAPB	Gene	56491
35026048	861	868	PTPIP51	Gene	67809
35026048	945	949	VAPB	Gene	56491
35026048	950	957	PTPIP51	Gene	67809
35026048	1046	1054	patients	Species	9606
35026048	1064	1067	ALS	Disease	MESH:D000690
35026048	1068	1071	FTD	Disease	MESH:D057180
35026048	1083	1090	C9orf72	Gene	203228
35026048	1136	1143	C9orf72	Gene	203228
35026048	1155	1159	mice	Species	10090
35026048	1170	1174	mice	Species	10090
35026048	1194	1198	VAPB	Gene	56491
35026048	1199	1206	PTPIP51	Gene	67809
35026048	1321	1331	neurotoxic	Disease	MESH:D020258
35026048	1349	1353	VAPB	Gene	9217
35026048	1354	1361	PTPIP51	Gene	67809
35026048	1476	1484	GSK3beta	Gene	56637
35026048	1517	1521	VAPB	Gene	56491
35026048	1522	1529	PTPIP51	Gene	67809
35026048	1592	1596	Ca2+	Chemical	-
35026048	1664	1668	VAPB	Gene	9217
35026048	1669	1676	PTPIP51	Gene	67809
35026048	1765	1768	ALS	Disease	MESH:D000690
35026048	1769	1772	FTD	Disease	MESH:D057180
35026048	1885	1892	C9orf72	Gene	203228
35026048	1902	1910	toxicity	Disease	MESH:D064420
35026048	Bind	67809	9217
35026048	Association	56491	56637
35026048	Association	MESH:D000690	56491
35026048	Association	MESH:C531617	203228
35026048	Association	203228	67809
35026048	Association	MESH:D020258	9217
35026048	Association	MESH:D000690	67809
35026048	Association	56491	67809
35026048	Association	MESH:D020258	203228
35026048	Association	56637	67809
35026048	Association	MESH:D057180	203228
35026048	Association	MESH:D064420	203228
35026048	Association	MESH:D020258	67809
35026048	Association	203228	56491
35026048	Association	MESH:D020258	56637
35026048	Association	MESH:D000690	203228

